Pittsburgh, PANCT06928246Now EnrollingIRB Ready

Atopic Dermatitis (AD) Clinical Trial in Pittsburgh, PA

Access cutting-edge atopic dermatitis (ad) treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.

Sponsored by Daniel Kaplan

Quick Self-Assessment

See if you qualify for this Pittsburgh location

Preparing your pre-screening questions…

Expert Care in Pittsburgh

Access atopic dermatitis (ad) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atopic dermatitis (ad) treatment provided free

Apply for This Pittsburgh Location

Check if you qualify for this atopic dermatitis (ad) clinical trial in Pittsburgh, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pittsburgh

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pittsburgh site if eligible
  4. 4Begin participation

About This Atopic Dermatitis (AD) Study in Pittsburgh

The purpose of this study is to understand cellular and molecular interactions in the skin of participants with mild-to-moderate AD, and how botulinum toxin alters these interactions.

Sponsor: Daniel Kaplan

Who Can Participate

Inclusion Criteria

Patients 18 years or older at time of consent
Mild-to-Moderate AD, defined as:
No past biologic therapy
No systemic therapy for 3 months
No topical therapy for treatment of AD for 4 weeks Phase 2:
Patients 18 years or older at time of consent
Mild-to-Moderate AD, defined as:
At least one patch of eczema of at least 5 cm in diameter
No past biologic therapy
No systemic therapy for 3 months
No topical therapy for treatment of AD for 4 weeks

Exclusion Criteria

Age less than 18 years old
Pregnant or breastfeeding
Has medical comorbidity such as end stage congestive heart failure or coagulopathy that is a relative contradiction to skin biopsy procedure
Has had prior exposure to biologic treatments or has had prior treatment with systemic non-biologics (e.g. methotrexate) within 12 weeks
Has used topical therapy for treatment of AD within 4 weeks Phase 2:
Patients enrolled in Phase 1
Age less than 18 years old
Pregnant or breastfeeding
Has medical comorbidity such as end stage congestive heart failure or coagulopathy that is a relative contradiction to skin biopsy procedure
Has had prior exposure to biologic treatments or has had prior treatment with systemic non-biologics (e.g. methotrexate) within 12 weeks
Has used topical therapy for treatment of AD within 4 weeks

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pittsburgh?

Yes, this clinical trial (NCT06928246) has an active research site in Pittsburgh, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atopic Dermatitis (AD) Treatment Options in Pittsburgh, PA

If you're searching for atopic dermatitis (ad) treatment options in Pittsburgh, PA, this clinical trial (NCT06928246) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis (ad) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all atopic dermatitis (ad) clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Pittsburgh, PA

See all alzheimers disease clinical trials recruiting in Pittsburgh — not just this study.

Browse Alzheimers Disease Trials in Pittsburgh

Ready to Join in Pittsburgh?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pittsburgh, PA